microfluidics Scienion, Cellenion Enter Exclusive Licensing Deal, Partnership With Pacific Northwest National Lab The two companies have exclusively licensed PNNL's microfluidic NanoPOTS platform and entered into a research agreement with EMSL to develop it toward commercial use. Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more. Capio Biosciences, BioView to Explore Integration of Circulating Tumor Cell Technologies The companies are conducting a study to evaluate their combined platforms for the detection and characterization of CTCs in prostate cancer. Deepcell, UCLA Partner to Study AI Cell Biology Platform The company said the collaboration is the first under an academic partnership program to refine and advance its technology and explore specific applications. TellBio, ARUP Laboratories to Explore CTC Collection Platform for Cancer Research Premium ARUP hopes to use TellBio's platform for several applications in solid tumor types, including prostate and gynecological cancers. May 17, 2021 Namocell, SingLab Technologies Ink Distribution Agreement for Singapore May 12, 2021 Nuclera Acquires E Ink Digital Microfluidics Business May 12, 2021 Berkeley Lights to Launch Subscription Option for Smaller Biotech Firms Premium May 11, 2021 Berkeley Lights Q1 Revenues Grow 35 Percent Mar 31, 2021 Biocept Prepares for First FDA Foray With CSF Liquid Biopsy Brain Metastases Assay Premium Mar 29, 2021 Biocept Q4 Revenues Spike as COVID-19 Testing Continues to Soar, Core Cancer Tests Lag Mar 18, 2021 Namocell, OLS OMNI Life Science Sign European Distribution Agreement Mar 3, 2021 Deepcell Advancing AI-Driven Cell Morphology Tech for Single-Cell Genomics, Liquid Biopsy Premium Feb 25, 2021 Miroculus Raises $45M in Extended Series B Financing Feb 10, 2021 Fluidigm Q4 Revenues Grow 38 Percent on COVID-19-Driven Microfluidics Growth Jan 25, 2021 Fluxergy Aiming to Provide Low-Cost, Multimodal Testing for SARS-CoV-2, Other Disease Targets Premium Dec 28, 2020 COVID-19 Pandemic Accelerated Development of CRISPR as a Diagnostic Platform in 2020 Dec 18, 2020 BioView, Ruby Nanomed Form Circulating Tumor Cell Analysis Partnership Dec 7, 2020 Deepcell Closes $20M Series A Financing Round Nov 18, 2020 Stanford Researchers Combine CRISPR, Microfluidics, Electric Fields for SARS-CoV-2 Dx Premium Nov 17, 2020 New NGS-Based Tissue Analysis Method Offers Spatial Detail on Transcriptome, Proteins Premium Nov 9, 2020 Savran Technologies to Target Breast Cancer Recurrence with Circulating Tumor Cell Platform Premium Nov 5, 2020 Fluidigm Q3 Revenues Jump 50 Percent Driven by COVID-19 Testing Oct 8, 2020 Fluidigm to Offer Coronavirus Saliva Test to US Colleges, Universities at Low Cost Sep 29, 2020 Fluidigm Finalizes $34M NIH Contract for SARS-CoV-2 Assay Production Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.